The objectives of Core B (Pilot Projects) at CCHl-EVC are to provide funding of research proposals that are focused on studies of Human Immunology that Involve agents classified as belonging to category A-C by the NIAID, NIH, which have the highest scientific merit and likelihood of success In obtaining extramural grant support. The funding is to generate data that serve as a foundation for the formulation of mechanistically and hypotheses driven projects. Our success in choosing Pilot Project grant applications Is exemplified by the successful funding of 3 NIH ROI grants, 2 grants as part of NIH program project proposals, a R56 grant, a US Army grant and a 5-yr Burroughs Wellcome grant. In addition, these funded Pilot Projects have resulted In contributing to the publication of 17 peer reviewed journal articles. Of importance to note is the fact that 90% of the Pilot Projects that were funded Included investigators that were NOT part of the CCHI-EVC In strong support of one of the major objectives of this U19 award, that Is, to encourage applications to broaden the community of investigators that are focused on performing studies of Human Immunology involving agents of biothreat. We hope to continue to match and exceed this rate of success under the present application and continue our efforts to encourage applications from "Young Investigators". To this end, we have assembled a team of outstanding senior scientists, Drs. Jerry Boss, Max Cooper, Inger Damon, Ignacio Sanz, Paul Spearman and Sam Speck, who will serve as members of the scientific review panel. We shall continue to solicit proposals via our web-site and various Emory LIST-SERV's. The top 2-3 application/year are funded. The applicants must provide a 6-month and a final progress report which Includes the list of publications that Include credit to Pilot Project funding mechanism and extramural grants that are submitted/funded. Additionally, It is our objective to provide guidance as to which avenues the applicants can take to seek extramural research funding. We also promote the presentation of the data by the funded Investigators as part of the yearly symposia organized by the Administrative Core. Thus, Core B will continue to build on and expand the success of human immunology studies at CCHI-EVC.

Public Health Relevance

To support young Investigators, who are working on the human immunology of select bio-defense pathogens to generate preliminary data and to apply for grants from NIH and other major funding agencies for advancing their career goals In the study of Human Immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI057266-11
Application #
8724845
Study Section
Special Emphasis Panel (ZAI1-LAR-I (J1))
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
11
Fiscal Year
2014
Total Cost
$132,918
Indirect Cost
$32,918
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Fang, Fengqin; Yu, Mingcan; Cavanagh, Mary M et al. (2016) Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell Rep 14:1218-31
Ravindran, Rajesh; Loebbermann, Jens; Nakaya, Helder I et al. (2016) The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature 531:523-7
Chandele, Anmol; Sewatanon, Jaturong; Gunisetty, Sivaram et al. (2016) Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol 90:11259-11278
Neu, Karlynn E; Henry Dunand, Carole J; Wilson, Patrick C (2016) Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr Opin Immunol 42:48-55
DiLillo, David J; Palese, Peter; Wilson, Patrick C et al. (2016) Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J Clin Invest 126:605-10
Henry Dunand, Carole J; Leon, Paul E; Huang, Min et al. (2016) Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host Microbe 19:800-13
Qi, Qian; Cavanagh, Mary M; Le Saux, Sabine et al. (2016) Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med 8:332ra46
Ho, Irvin Y; Bunker, Jeffrey J; Erickson, Steven A et al. (2016) Refined protocol for generating monoclonal antibodies from single human and murine B cells. J Immunol Methods 438:67-70
Nakaya, Helder I; Clutterbuck, Elizabeth; Kazmin, Dmitri et al. (2016) Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A 113:1853-8
Burke, Rachel M; Suchdev, Parminder S; Rebolledo, Paulina A et al. (2016) Predictors of Inflammation in a Cohort of Bolivian Infants and Toddlers. Am J Trop Med Hyg 95:954-963

Showing the most recent 10 out of 202 publications